ACT Lung Health Intervention: Phase Two — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ACT Lung Health Intervention: Phase Two — Stella

Recruiting

Back to Smoking Cessation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Massachusetts-Boston, Boston, Massachusetts

Key details

Sponsor

Dana-Farber Cancer Institute

Collaborators

National Cancer Institute (NCI), University of Massachusetts, Boston

Enrollment target

~50 participants

Started

November 2025

Primary completion

November 2026

Age range

18 Years – 100 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov